Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

Transplantation

Volumn 61, Issue 9, 1996, Pages 1358-1364

  Mcgory, Robert W ^a   Ishitani, Michael B ^a   Oliveira, Walter M ^a   Stevenson, William C ^a   Mccullough, Christopher S ^a   Dickson, Rolland C ^a   Caldwell, Stephen H ^a   Pruett, Timothy L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ALLOGRAFT; ANTIGEN DETECTION; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DRUG HALF LIFE; FEMALE; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RECURRENCE RISK; REINFECTION; TREATMENT OUTCOME;

ADULT; CHRONIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOSUPPRESSION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0029879163     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605150-00013     Document Type: Article

References (38)

1. Rakela J, Wooten RS, Batts KP, Perkins JD, Taswell HF, Krom RAF. Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clin Proc 1989; 64: 429.
2. Lavine JE, Lake JR, Ascher NL, Ferrell LD, Ganem D, Wright TL. Persistent hepatitis B virus following interferon-alpha therapy and liver transplantation. Gastroenterology 1991; 100: 263.
3. Davies SE, Portmann BC, O'Grady JG, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150.
4. Demetris AJ, Todo S, Van Thiel DH, et al. Evolution of hepatitis B virus liver disease after hepatic replacement (practical and theoretical considerations). Am J Pathol 1990; 137: 667.
5. Lucey MR, Graham DM, Martin P, et al. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 1992; 33: 1390.
6. Monsour HP, Schafer DF, Ozaki CF, et al. Orthotopic liver transplantation (OLT) for chronic hepatitis B and cirrhosis. Gastroenterology 1990; 102: A854.
7. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842.
8. Colledan M, Gislon M, Doglia M, et al. Liver transplantation in patients with B viral hepatitis and delta infection. Transplant Proc 1987; 19: 4073.
9. Samuel D, Bismuth A, Mathieu D, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991; 337: 813.
10. Ferla G, Colledan M, Doglia M, et al. B hepatitis and liver transplantation. Transplant Proc 1988; 20: 566.
11. Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H Jr. Retransplantation in hepatitis B - a multicenter experience. Transplantation 1994; 57: 823.
12. Lake JR, Wright TL. Liver transplantation for patients with hepatitis B: what have we learned from our results? [Editorial; Comment]. Hepatology 1991; 13: 796.
13. Lake JR, Wright T, Ferrell L, Donegan E, Roberts J, Ascher N. Hepatitis C and B in liver transplantation [Review]. Transplant Proc 1993; 25: 2006.
14. ten Kate FJW, Schalm SW, Willemse PJA, Blok APR, Heijtink RA, Terpstra OT. Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. J Hepatol 1992; 14: 168.
15. Müller R, Lauchart W, Farle M, Klien H, Niehoff G, Pichylmayr R. Simultaneous passive-active immunization for preventing hepatitis B virus reinfection in hepatitis B surface antigen-positive liver transplant recipients. In: Viral hepatitis and liver disease: proceedings of the international symposium on viral hepatitis and liver disease, held at the Barbizon Centre, London, May 26, 1987. New York: Liss, 1988: 810.
16. Johnson PJ. Liver transplantation in carriers of the HBsAg: role of short-term passive prophylaxis with immunoglobulin [Letter; Comment]. J Hepatol 1992; 14: 411.
17. Samuel D, Bismuth A, Serres C, et al. HBV infection after liver transplantation in HBsAg positive patients: experience with long-term immunoprophylaxis. Transplant Proc 1991; 23: 1492.
18. Müller R, Gubernatis G, Farie M, et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13: 90.
19. Ishitani M, McGory R, Kiyasu P, et al. Six month versus continued intermittent HBIG administration in the prevention of hepatitis B reinfection after liver transplantation. Gastroenterology 1991; 104: A920.
20. Bismuth A, Arulnaden JL, Samuel D, et al. Relapse prevention in liver transplant patients treated for liver involvement due to hepatitis B virus. Rev Fr Transfusion Hemobiol 1992; 35: 107.
21. Rossi G, Grendele M, Colledan M, et al. Prevention of hepatitis B virus reinfection after liver transplantation. Transplant Proc 1991; 23: 1969.
22. Mora NP, Klintmalm GB, Poplawski SS, et al. Recurrence of hepatitis B after liver transplantation: does hepatitis-B-immunoglobulin modify the recurrent disease? Transplant Proc 1990; 22: 1549.
23. Wright TL, Zeldis JB, Mamish D, et al. Graft infection with hepatitis B (HBV) following liver transplantation (OLTx): prognostic importance of viral replication. Hepatology 1990; 12: 867.
24. Lauchart W, Muller R, Pichlmayr R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987; 19: 2387.
25. Lauchart W, Muller R, Pichlmayr R. Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987; 19: 4051.
26. Fong TL, DiBisceglie AM, Biswas R, et al. High levels of viral replication during acute hepatitis B infection predict progression to chronicity. J Med Virol 1994; 43: 155.
27. Hsu S, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577.
28. Levy RH, Bauer LA. Basic pharmacokinetics. Ther Drug Monit 1986; 8: 47.
29. König V, Hopf U, Neuhaus P, et al. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation 1994; 58: 553.
30. Neurath AR, Strick N. Antigenic mimicry of an immunoglobulin A epitope by a hepatitis B virus cell attachment site. Virology 1990; 178: 631.
31. McLachlan A (Ed). Molecular biology of the hepatitis B virus. Boca Raton, FL: CRC Press, 1991: 330.
32. Machida A, Kirshimoto S, Ohnuma H, et al. A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 1984; 86: 910.
33. Feray C, Zignega AL, Samuel D, et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. Transplant 1990; 49: 1155.
34. Mason A, Yoffe B, Noonan C, et al. Hepatitis B virus DNA in peripheral blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology 1992; 16: 36.
35. DiBisceglie AM, Hoffnagle JH. Hepatitis B virus replication within the human spleen. J Clin Microbiol 1990; 28: 2850.
36. Wahl M, Hermodsson S, Kjellman H, Iwarson S. Recovery and turnover rate of hepatitis B immunoglobulin in volunteers. Dev Biol Stand 1983; 54: 341.
37. Kruger M, Tillmann H, Trautwein C, et al. Treatment of hepatitis B virus reinfection after liver transplantation with famciclovir. Hepatology 1994; 20: A130.
38. Samuel D, Gigou M, Feray C, et al. Use of ganciclovir in the treatment of hepatitis B after liver transplantation [Abstract 164]. Paper presented at the 15th World Congress of The Transplantation Society, Kyoto, Japan, August 1994.